Roche Invests In Xenon’s Novel Anemia Treatment Platform
This article was originally published in The Pink Sheet Daily
Executive Summary
Two-year licensing, equity investment deal with the Canadian drug discovery firm will explore protein modulators to treat anemia of inflammation.